Investors Encouraged to Join Class Action Against PepGen
Bragar Eagel & Squire, P.C. is actively engaging with investors who have experienced losses as a result of their investment in PepGen (PEPG). The firm is reaching out specifically to those who acquired securities between specified periods to explore their legal options.
PepGen Under Legal Scrutiny
Recently, a class action lawsuit has been initiated against PepGen, Inc. in the United States District Court for the Eastern District of New York. This legal action targets all individuals and entities that purchased or acquired PepGen securities during the defined class period. Investors who wish to take part in this lawsuit must apply by the provided deadline.
Understanding the Allegations
The lawsuit stems from claims made against the company regarding misleading statements related to its business and operational practices. It has been alleged that throughout the class period, Defendants failed to disclose critical information regarding the efficacy and safety of one of PepGen's main products, PGN-EDO51. There are accusations that the CONNECT2 study, which is vital for FDA approval, was insufficient and potentially dangerous.
Key Dates for Investors
Those impacted have until the specified date to apply as lead plaintiff in the lawsuit. This deadline signifies a critical window for potential claimants to step forward and assert their rights. Those who purchased PepGen shares during this time are particularly encouraged to consult legal experts to discuss their situation.
Next Steps for Affected Investors
Bragar Eagel & Squire invites investors who believe they have suffered losses to reach out to them directly. The firm offers direct communication avenues for those interested in understanding their legal rights and the allegations surrounding PepGen.
Contact Information for Inquiries
Investors can get in touch with Bragar Eagel & Squire by phone. Their legal partners, including Brandon Walker and Marion Passmore, are poised to offer guidance and clarification about the class action.
About Bragar Eagel & Squire, P.C.
This law firm has built a reputation for advocating for the rights of investors across the nation. With significant expertise in handling complex litigation, they are committed to representing individual and institutional investors involved in securities disputes.
Frequently Asked Questions
What is the class action lawsuit about?
The lawsuit concerns misleading statements made by PepGen regarding its products and operations which negatively affected stockholders.
Who can participate in the class action?
Any investor who purchased PepGen securities within the specified time frame can apply to join the class action.
How can I contact Bragar Eagel & Squire?
Investors can reach out to the firm via phone at (212) 355-4648 or through their email.
What should I do if I’ve lost money on PepGen?
If you have incurred losses, it is advisable to consult with a legal professional regarding your rights and potential actions.
What are the next steps in the lawsuit?
Investors should keep an eye on deadlines for filing and seek legal advice to understand their positions as claimants.
